Atara Biotherapeutics (ATRA) Gross Margin (2022 - 2026)
Atara Biotherapeutics (ATRA) posted Gross Margin of 75.97% for Q1 2026, down 18.73% on a QoQ basis from 93.48% in Q4 2025, and down 321.0% year-over-year from 34.38% in Q1 2025.
Atara Biotherapeutics (ATRA) Gross Margin (2022 - 2026) Analysis & Trends
Atara Biotherapeutics' Gross Margin history runs 5 years deep, the most recent figure standing at 75.97% for Q1 2026.
- Quarterly Gross Margin fell 321.0% year-over-year to 75.97% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 96.12% (up 1588.0% YoY) and the FY2025 annual result came in at 82.44%, down 127.0% from the prior year.
- Gross Margin was 75.97% for Q1 2026 at Atara Biotherapeutics, down from 93.48% in the prior quarter.
- Across five years, Gross Margin topped out at 204.98% in Q4 2023 and bottomed at 1665.24% in Q2 2023.
- A 5-year average of 20.94% and a median of 88.29% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin plunged 176524 bps — and 2024, when it surged 174909 bps.
- Atara Biotherapeutics' Gross Margin stood at 100.0% in 2022, then surged by 105 bps to 204.98% in 2023, then sank by 61 bps to 79.25% in 2024, then rose by 18 bps to 93.48% in 2025, then dropped by 19 bps to 75.97% in 2026.
- Business Quant data shows ATRA's Gross Margin at 75.97% in Q1 2026, 93.48% in Q4 2025, and 96.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 75.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.97% |
| Dec 31, 2025 | 93.48% |
| Sep 30, 2025 | 96.67% |
| Jun 30, 2025 | 96.85% |
| Mar 31, 2025 | 79.18% |
| Dec 31, 2024 | 79.25% |
| Sep 30, 2024 | 81.08% |
| Jun 30, 2024 | 83.84% |
| Mar 31, 2024 | 92.74% |
| Dec 31, 2023 | 204.98% |
| Sep 30, 2023 | -29.46% |
| Jun 30, 2023 | -1,665.24% |
| Mar 31, 2023 | 75.57% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 100.00% |